Location: Miami, FL
CIK: 0001325083 · Show all filings
Period: Q2 2018 (← Previous) (Next →)
Filing Date: Aug 14, 2018
Total Value: $118M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Abeona Therapeutics Inc | 2,359,767 | $37.76M | 32.1% | $4.97 | — | COM | 00289Y107 |
| — | Biohaven Pharmactl Hldg Co L | 749,815 | $29.63M | 25.2% | $25.00 | — | COM | G11196105 |
| — | Corbus Pharmaceuticals HLDGS | 3,913,874 | $19.77M | 16.8% | $4.42 | — | COM | 21833P103 |
| — | Electrocore Inc | 396,825 | $6.551M | 5.6% | $16.51 | — | COM | 28531P103 |
| — | Ampio Pharmaceuticals Inc. | 2,595,484 | $5.71M | 4.9% | $6.03 | — | COM | 03209T109 |
| KRYS | Krystal Biotech Inc | 300,000 | $4.461M | 3.8% | $10.08 | +11.3% | COM | 501147102 |
| ENTX | Entera Bio Ltd | 475,540 | $2.996M | 2.5% | $6.29 | 0.0% | SHS | M40527109 |
| — | Galmed Pharmaceuticals Ltd | 210,000 | $2.499M | 2.1% | $11.90 | — | SHS | M47238106 |
| — | Vascular Biogenics LTD | 896,771 | $1.973M | 1.7% | $4.71 | — | COM | M96883109 |
| AVXL | Anavex Life Sciences Corp | 724,205 | $1.897M | 1.6% | $3.56 | -21.6% | COM NEW | 032797300 |
| ALDX | Aldeyra Therapeutics Inc | 124,096 | $987K | 0.8% | $10.20 | -21.8% | COM | 01438T106 |
| — | Eiger Biopharmaceuticals Inc | 75,238 | $918K | 0.8% | $9.85 | — | COM | 28249U105 |
| — | Soligenix Inc. | 837,800 | $813K | 0.7% | $2.11 | — | COM | 834223307 |
| VNRX | Volition RX LTD | 351,538 | $703K | 0.6% | $3.75 | -40.4% | COM | 928661107 |
| — | Evoke Pharma Inc | 275,000 | $688K | 0.6% | $2.99 | — | COM | 30049G104 |
| NAGE | Chromadex Corp | 47,866 | $178K | 0.2% | $3.80 | 0.0% | COM NEW | 171077407 |
| — | Lipocine Inc New | 50,000 | $65,000 | 0.1% | $1.30 | — | COM | 53630X104 |
| — | Catasys Inc | 9,081 | $61,000 | 0.1% | $6.72 | — | COM | 149049504 |
| — | Advaxis Inc. | 112,500 | $20,000 | 0.0% | $3.96 | — | W EXP 07/15/201 | 007624117 |